Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Buttyan

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
European Urology|February 12, 2008
Editorial comment on: Hedgehog signalling in androgen independent prostate cancerMengqian Chen, Ralph Buttyan
The Journal of Urology|March 12, 2003
Editorial: hormone therapies for prostate cancer--acute disease control, chronic disease progressionDelores J Lamb, Ralph Buttyan
Discovery Medicine|March 9, 2007
Dietary agents/supplements hit the clinic for prostate cancer chemopreventionDebra L Bemis, Ralph Buttyan
The Journal of Urology|April 18, 2007
Molecularly targeted therapies for renal cell cancer: TRAIL research advancesRalph Buttyan, Badar M Mian
Oncoscience|June 2, 2018
Hedgehog in prostate cancer explainedRalph Buttyan, Na Li, Shabnam Massah
Expert Review of Endocrinology & Metabolism|July 22, 2011
The hedgehog/Gli signaling paradigm in prostate cancerMengqian Chen, Richard Carkner, Ralph Buttyan
Current Molecular Medicine|August 19, 2007
The Wnt/beta-catenin pathway in Wilms tumors and prostate cancersBenjamin Tycko, Chi-Ming Li, Ralph Buttyan
The Journal of Urology|April 12, 2005
A problem with a chaperoneDolores J Lamb, Lixin Zhang, Ralph Buttyan
Scandinavian Journal of Urology and Nephrology. Supplementum|November 17, 2004
Role of angiogenesis in bladder response to partial outlet obstructionRobert Levin, Paul Chichester, Sheila Levin, et al.
Oncotarget|July 25, 2018
Correction: Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cellsRuiqi Chen, Yinan Li, Ralph Buttyan, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
European Urology|February 12, 2008
Editorial comment on: Hedgehog signalling in androgen independent prostate cancerMengqian Chen, Ralph Buttyan
The Journal of Urology|March 12, 2003
Editorial: hormone therapies for prostate cancer--acute disease control, chronic disease progressionDelores J Lamb, Ralph Buttyan
Discovery Medicine|March 9, 2007
Dietary agents/supplements hit the clinic for prostate cancer chemopreventionDebra L Bemis, Ralph Buttyan
The Journal of Urology|April 18, 2007
Molecularly targeted therapies for renal cell cancer: TRAIL research advancesRalph Buttyan, Badar M Mian
Oncoscience|June 2, 2018
Hedgehog in prostate cancer explainedRalph Buttyan, Na Li, Shabnam Massah
Expert Review of Endocrinology & Metabolism|July 22, 2011
The hedgehog/Gli signaling paradigm in prostate cancerMengqian Chen, Richard Carkner, Ralph Buttyan
Current Molecular Medicine|August 19, 2007
The Wnt/beta-catenin pathway in Wilms tumors and prostate cancersBenjamin Tycko, Chi-Ming Li, Ralph Buttyan
The Journal of Urology|April 12, 2005
A problem with a chaperoneDolores J Lamb, Lixin Zhang, Ralph Buttyan
Scandinavian Journal of Urology and Nephrology. Supplementum|November 17, 2004
Role of angiogenesis in bladder response to partial outlet obstructionRobert Levin, Paul Chichester, Sheila Levin, et al.
Oncotarget|July 25, 2018
Correction: Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cellsRuiqi Chen, Yinan Li, Ralph Buttyan, et al.
Pageof 7